<code id='EBC1D4F5C2'></code><style id='EBC1D4F5C2'></style>

<acronym id='EBC1D4F5C2'></acronym>

<center id='EBC1D4F5C2'><center id='EBC1D4F5C2'><tfoot id='EBC1D4F5C2'></tfoot></center><abbr id='EBC1D4F5C2'><dir id='EBC1D4F5C2'><tfoot id='EBC1D4F5C2'></tfoot><noframes id='EBC1D4F5C2'>

<optgroup id='EBC1D4F5C2'><strike id='EBC1D4F5C2'><sup id='EBC1D4F5C2'></sup></strike><code id='EBC1D4F5C2'></code></optgroup>

<b id='EBC1D4F5C2'><label id='EBC1D4F5C2'><select id='EBC1D4F5C2'><dt id='EBC1D4F5C2'><span id='EBC1D4F5C2'></span></dt></select></label></b><u id='EBC1D4F5C2'></u>

~~<i id='EBC1D4F5C2'><strike id='EBC1D4F5C2'><tt id='EBC1D4F5C2'><pre id='EBC1D4F5C2'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

fashion

author：entertainment 2025-09-30 04:37:21 Page View：89111

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

advertisement

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Popular nasal decongestant doesn't actually relieve congestion
Next article： What does generative AI mean for health care? We asked experts

focus

Activists slam private health insurers over coverage restrictions

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

UnitedHealth’s Optum accused of antitrust violations in California

UnitedHealth’s Optum accused of antitrust violations in California

EmanateHealthsuedUnitedHealth'sOptum,allegingtheinsurerpushedittoagreenottocompeteforprimarycarephys

Apple is now the first public company to be valued at $3 trillion

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Hospitals consider fixing cancer drug shortages on their own

CivicaRxisconsideringamoveintochemotherapiesamiddrugshortages.AdobeWASHINGTON—Anonprofitformedbyhosp

read more